294 related articles for article (PubMed ID: 30225610)
1. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
2. Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?
Yadav AK; Sharma R; Kandasamy D; Pradhan RK; Garg PK; Bhalla AS; Gamanagatti S; Srivastava DN; Sahni P; Upadhyay AD
Pancreatology; 2016; 16(6):979-987. PubMed ID: 27568845
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis and PDAC: association and differentiation.
Elsherif SB; Virarkar M; Javadi S; Ibarra-Rovira JJ; Tamm EP; Bhosale PR
Abdom Radiol (NY); 2020 May; 45(5):1324-1337. PubMed ID: 31705251
[TBL] [Abstract][Full Text] [Related]
5. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
[TBL] [Abstract][Full Text] [Related]
6. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging.
Xu J; Liang Z; Hao S; Zhu L; Ashish M; Jin C; Fu D; Ni Q
Abdom Imaging; 2009 Nov; 34(6):759-66. PubMed ID: 19672566
[TBL] [Abstract][Full Text] [Related]
8. 64-slice CT perfusion imaging of pancreatic adenocarcinoma and mass-forming chronic pancreatitis.
Lu N; Feng XY; Hao SJ; Liang ZH; Jin C; Qiang JW; Guo QY
Acad Radiol; 2011 Jan; 18(1):81-8. PubMed ID: 20951612
[TBL] [Abstract][Full Text] [Related]
9. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience.
Hamdy A; Ichikawa Y; Toyomasu Y; Nagata M; Nagasawa N; Nomoto Y; Sami H; Sakuma H
Radiology; 2019 Sep; 292(3):628-635. PubMed ID: 31287389
[TBL] [Abstract][Full Text] [Related]
10. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
[TBL] [Abstract][Full Text] [Related]
11. Computed Tomography Perfusion Analysis of Pancreatic Adenocarcinoma using Deconvolution, Maximum Slope, and Patlak Methods - Evaluation of Diagnostic Accuracy and Interchangeability of Cut-Off Values.
Koell M; Klauss M; Skornitzke S; Mayer P; Fritz F; Stiller W; Grenacher L
Rofo; 2021 Sep; 193(9):1062-1073. PubMed ID: 33772484
[TBL] [Abstract][Full Text] [Related]
12. Lower energy levels and iodine-based material decomposition images increase pancreatic ductal adenocarcinoma conspicuity on rapid kV-switching dual-energy CT.
Aslan S; Camlidag I; Nural MS
Abdom Radiol (NY); 2019 Feb; 44(2):568-575. PubMed ID: 30155698
[TBL] [Abstract][Full Text] [Related]
13. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
15. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
16. CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging.
O'Malley RB; Cox D; Soloff EV; Zečević M; Green S; Coveler A; Busey JM; Wang CL
Abdom Radiol (NY); 2022 Nov; 47(11):3770-3781. PubMed ID: 35972550
[TBL] [Abstract][Full Text] [Related]
17. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas.
Kersting S; Konopke R; Kersting F; Volk A; Distler M; Bergert H; Saeger HD; Grützmann R; Bunk A
Gastroenterology; 2009 Dec; 137(6):1903-11. PubMed ID: 19715694
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging.
Huang WC; Sheng J; Chen SY; Lu JP
J Dig Dis; 2011 Oct; 12(5):401-8. PubMed ID: 21955434
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma.
O'Malley RB; Soloff EV; Coveler AL; Cox DH; Desai N; Busey JM; Valentin GM; Wang CL
Abdom Radiol (NY); 2021 May; 46(5):1992-2002. PubMed ID: 33079256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
